DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Share Price

Certificat

DE000MG4D096

Market Closed - Bid/Ask 12:07:35 06/07/2024 am IST After market 01:04:48 am
0.74 EUR 0.00% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS 0.755 +2.03%
Current month-2.63%
1 month+37.04%
Date Price Change
06/24/06 0.74 0.00%
03/24/03 0.74 -2.63%
02/24/02 0.76 +2.70%
01/24/01 0.74 -2.63%
28/24/28 0.76 +1.33%

Delayed Quote Börse Stuttgart

Last update July 06, 2024 at 12:07 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D09
ISINDE000MG4D096
Date issued 16/05/2024
Strike 80 $
Maturity 20/12/2024 (168 Days)
Parity 10 : 1
Emission price 0.34
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.77
Lowest since issue 0.33
Spread 0.01
Spread %1.33%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.52 USD
Average target price
83.43 USD
Spread / Average Target
+45.05%
Consensus